LMLennart T. Mars

Lennart T. Mars

*This is an algorithmically generated author record based on publicly available information.

Lennart T. Mars has a total of 157 co-authors. Here are the top co-authors by number of shared publications:

  • Roland Liblau

    Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France

    27 shared publications
  • Sabine Desbois

    INSERM UMR1043, Toulouse, F-31300, France CNRS, U5282, Toulouse, F-31300, France Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, F-31300, France

    8 shared publications
  • Eliane Piaggio

    INSERM U932, PSL University, Institut Curie Research Center, Paris, France

    5 shared publications
  • Jan Bauer

    Department of Neuroimmunology, Centre for Brain Research, Medical University of Vienna, Vienna, Austria

    5 shared publications
  • Nadège Carrié

    INSERM UMR1043, Toulouse, F-31300, France CNRS, U5282, Toulouse, F-31300, France Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, F-31300, France

    5 shared publications
  • Agnès Lehuen

    Université Paris Cité, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France (A.L.).

    4 shared publications

Latest Publications

  • Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies

    by Mathilde Bas, Aurélie Terrier, Emilie Jacque, Aurélie Dehenne, Virginie Pochet-Béghin, Cécile Beghin, Anne-Sophie Dezetter, Gilles Dupont, Anaïs Engrand, Benjamin Beaufils, et al.

    The long serum t1/2 of IgGs is ensured by their interaction with the neonatal Fc receptor (FcRn), which salvages IgG from intracellular degradation. Fc glycosylation is thought not to influence FcRn binding and IgG longevity in vivo. In this article, we demonstrate that hypersialylation of asparagine 297 (N297) enhances IgG serum persistence. This polarized glycosylation is achieved using a novel Fc mutation, a glutamate residue deletion at position 294 (Del) that endows IgGs with an up to 9-fold increase in serum lifespan. The strongest impact was observed when the Del was combined with Fc mutations improving FcRn binding (Del-FcRn+). Enzymatic desialylation of a Del-FcRn+ mutant or its production in a cell line unable to hypersialylate reduced the in vivo serum t1/2 of the desialylated mutants to that of native FcRn+ mutants. Consequently, our study proves that sialylation of the N297 sugar moiety has a direct impact on human IgG serum persistence.


  • Open Access

    Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis

    by Laurent Serre, Maeva Girard, Abdoulraouf Ramadan, Paul Menut, Nelly Rouquié, Liliana E Lucca, Karim Mahiddine, Bertrand Leobon, Lennart T. Mars, Sylvie Guerder

    The genetic predisposition to multiple sclerosis (MS) is most strongly conveyed by MHC class II haplotypes, possibly by shaping the autoimmune CD4 T cell repertoire. Whether Ag-processing enzymes contribute to MS susceptibility by editing the peptide repertoire presented by these MHC haplotypes is unclear. Thymus-specific serine protease (TSSP) is expressed by thymic epithelial cells and thymic dendritic cells (DCs) and, in these two stromal compartments, TSSP edits the peptide repertoire presented by class II molecules. We show in this article that TSSP increases experimental autoimmune encephalomyelitis severity by limiting central tolerance to myelin oligodendrocyte glycoprotein. The effect on experimental autoimmune encephalomyelitis severity was MHC class II allele dependent, because the lack of TSSP expression conferred protection in NOD mice but not in C57BL/6 mice. Importantly, although human thymic DCs express TSSP, individuals segregate into two groups having a high or 10-fold lower level of expression. Therefore, the level of TSSP expression by thymic DCs may modify the risk factors for MS conferred by some MHC class II haplotypes.


  • Open Access

    Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4+T cells specific for both a myelin and a neuronal self‐antigen in mice

    by Liliana E. Lucca, Pierre‐Paul Axisa, Meryem Aloulou, Corine Perals, Abdulraouf Ramadan, Pierre Rufas, Bruno Kyewski, Jens Derbinski, Nicolas Fazilleau, Lennart T. Mars, et al.

    T‐cell polyspecificity, predicting that individual T cells recognize a continuum of related ligands, implies that multiple antigens can tolerize T cells specific for a given self‐antigen. We previously showed in C57BL/6 mice that part of the CD4+T‐cell repertoire specific for myelin oligodendrocyte glycoprotein (MOG) 35–55 also recognizes the neuronal antigen neurofilament medium (NF‐M) 15–35. Such bi‐specific CD4+T cells are frequent and produce inflammatory cytokines after stimulation. Since T cells recognizing two self‐antigens would be expected to be tolerized more efficiently, this finding prompted us to study how polyspecificity impacts tolerance. We found that similar to MOG, NF‐M is expressed in the thymus by medullary thymic epithelial cells, a tolerogenic population. Nevertheless, the frequency, phenotype, and capacity to transfer experimental autoimmune encephalomyelitis (EAE) of MOG35‐55‐reactive CD4+T cells were increased in MOG‐deficient but not in NF‐M‐deficient mice. We found that presentation of NF‐M15‐35by I‐Abon dendritic cells is of short duration, suggesting unstable MHC class II binding. Consistently, introducing an MHC‐anchoring residue into NF‐M15‐35(NF‐M15‐35T20Y) increased its immunogenicity, activating a repertoire able to induce EAE. Our results show that in C57BL/6 mice bi‐specific encephalitogenic T cells manage to escape tolerization due to inefficient exposure to two self‐antigens.


  • In situexpansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS

    by Abdulraouf Ramadan, Liliana E. Lucca, Nadège Carrié, Sabine Desbois, Pierre-Paul Axisa, Myriam Hayder, Jan Bauer, Roland S. Liblau, Lennart T. Mars

    Polyspecific T cells recognizing multiple distinct self-antigens have been identified in multiple sclerosis and other organ-specific autoimmune diseases, but their pathophysiological relevance remains undetermined. Using a mouse model of multiple sclerosis, we show that autoimmune encephalomyelitis induction is strictly dependent on reactivation of pathogenic T cells by a peptide (35–55) derived from myelin oligodendrocyte glycoprotein (MOG). This disease-inducing response wanes after onset. Strikingly, the progression of disease is driven by the in situ activation and expansion of a minority of MOG35–55-specific T cells that also recognize neurofilament-medium (NF-M)15–35, an intermediate filament protein expressed in neurons. This mobilization of bispecific T cells is critical for disease progression as adoptive transfer of NF-M15–35/MOG35–55 bispecific T cell lines caused full-blown disease in wild-type but not NF-M-deficient recipients. Moreover, specific tolerance through injection of NF-M15–35 peptide at the peak of disease halted experimental autoimmune encephalomyelitis progression. Our findings highlight the importance of polyspecific autoreactive T cells in the aggravation and perpetuation of central nervous system autoimmunity.


  • Open Access

    Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice

    by Liliana E Lucca, Sabine Desbois, Abdulraouf Ramadan, Avraham Ben-Nun, Miriam Eisenstein, Nadège Carrié, Jean-Charles Guéry, Alessandro Sette, Phuong Nguyen, Terrence L. Geiger, et al.

    The recognition of multiple ligands by a single TCR is an intrinsic feature of T cell biology, with important consequences for physiological and pathological processes. Polyspecific T cells targeting distinct self-antigens have been identified in healthy individuals as well as in the context of autoimmunity. We have previously shown that the 2D2 TCR recognizes the myelin oligodendrocyte glycoprotein epitope (MOG)35–55 as well as an epitope within the axonal protein neurofilament medium (NF-M15–35) in H-2b mice. In this study, we assess whether this cross-reactivity is a common feature of the MOG35–55-specific T cell response. To this end, we analyzed the CD4 T cell response of MOG35–55-immunized C57BL/6 mice for cross-reactivity with NF-M15–35. Using Ag recall responses, we established that an important proportion of MOG35–55-specific CD4 T cells also responded to NF-M15–35 in all mice tested. To study the clonality of this response, we analyzed 22 MOG35–55-specific T cell hybridomas expressing distinct TCR. Seven hybridomas were found to cross-react with NF-M15–35. Using an alanine scan of NF-M18–30 and an in silico predictive model, we dissected the molecular basis of cross-reactivity between MOG35–55 and NF-M15–35. We established that NF-M F24, R26, and V27 proved important TCR contacts. Strikingly, the identified TCR contacts are conserved within MOG38–50. Our data indicate that due to linear sequence homology, part of the MOG35–55-specific T cell repertoire of all C57BL/6 mice also recognizes NF-M15–35, with potential implications for CNS autoimmunity.


  • Open Access

    Invariant NKT Cells Regulate the CD8 T Cell Response during Theiler's Virus Infection

    by Lennart T. Mars, Magali Mas, Lucie Beaudoin, Jan Bauer, Maria Leite-De-Moraes, Agnès Lehuen, Jean-Francois Bureau, Roland S. Liblau

    Invariant NKT cells are innate lymphocytes with a broad tissue distribution. Here we demonstrate that iNKT cells reside in the central nervous system (CNS) in the absence of inflammation. Their presence in the CNS dramatically augments following inoculation of C57Bl/6 mice with the neurotropic Theiler's murine encephalomyelitis virus (TMEV). At the peak of inflammation the cellular infiltrate comprises 45 000 iNKT cells for 1 250 CD8 T cells specific for the immunodominant TMEV epitope. To study the interaction between these two T cell subsets, we infected both iNKT cell deficient Jα18-/- mice and iNKT cell enriched Vα14 transgenic mice with TMEV. The CD8 T cell response readily cleared TMEV infection in the iNKT cell deficient mice. However, in the iNKT cell enriched mice TMEV infection persisted and was associated with significant mortality. This was caused by the inhibition of the CD8 T cell response in the cervical lymph nodes and spleen after T cell priming. Taken together we demonstrate that iNKT cells reside in the CNS in the absence of inflammation and that their enrichment is associated with the inhibition of the anti-viral CD8 T cell response and an augmented mortality during acute encephalomyelitis.


  • In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

    by Guillaume Martin-Blondel, Jan Bauer, Victor Cuvinciuc, Emmanuelle Uro-Coste, Alexa Debard, Patrice Massip, Marie-Bernadette Delisle, Hans Lassmann, Bruno Marchou, Lennart T. Mars, et al.

    Objective: To determine the pathophysiologic features of progressive multifocal leukoencephalopathy (PML) associated with immune reconstitution inflammatory syndrome (PML-IRIS) in HIV-infected patients. Methods: In a cross-sectional study, we retrospectively analyzed 11 HIV-infected patients with a firm diagnosis of PML-IRIS. Brain biopsies were collected from 5 patients and their histopathologic features were compared to those of 4 HIV-infected patients with classic PML. Results: PML-IRIS developed soon after initiation of antiretroviral therapy in late-presenting HIV-infected patients. The lesions from the 5 biopsied PML-IRIS patients were characterized by a reduction in the density of JC virus (JCV)–infected cells when compared to the 4 patients with PML (11.1 ± 3.2/mm2 vs 51.2 ± 4.3/mm2, p = 0.01). Comparing the 5 patients with PML-IRIS vs the 4 patients with PML, this correlated with an increased accumulation of CD8+ T cells (818.2 ± 192.8/mm2 vs 52.5 ± 10.6/mm2, p = 0.01), CD20+ B cells (33.4 ± 13.5/mm2 vs 0.5 ± 0.5/mm2, p = 0.01), and CD138+ plasma cells (177 ± 84.1/mm2 vs 0.25 ± 0.25/mm2, p = 0.01), while the number of CD68+ macrophages/microglia did not differ. The ratio between CD8+ T cells and JCV-infected cells was 70 times higher in the 5 patients with PML-IRIS. These findings indicate a clear relationship between an enhanced recruitment of CD8+ T cells and the associated control of the JCV infection. Conclusions: Our data provide in situ evidence that PML-IRIS brain lesions are enriched in cytotoxic CD8+ T cells that engage JCV-infected oligodendrocytes. This leads to a better control of JCV dissemination, but at the cost of oligodendrocyte cell death and demyelination.


  • Open Access

    Tc17 CD8+ T Cells Potentiate Th1-Mediated Autoimmune Diabetes in a Mouse Model

    by Amit Saxena, Sabine Desbois, Nadège Carrié, Myriam Lawand, Lennart T. Mars, Roland S. Liblau

    An increase in IL-17–producing CD8+ T (Tc17) cells has been reported in the peripheral blood of children with recent onset type 1 diabetes (T1D), but their contribution to disease pathogenesis is still unknown. To directly study the pathogenic potential of β cell-specific Tc17 cells, we used an experimental model of T1D based on the expression of the neo-self Ag hemagglutinin (HA) in the β cells of the pancreas. When transferred alone, the IL-17–producing HA-specific CD8+ T cells homed to the pancreatic lymph nodes without causing any pancreatic infiltration or tissue destruction. When transferred together with small numbers of diabetogenic HA-specific CD4+ T cells, a strikingly different phenotype developed. Under these conditions, Tc17 cells sustained disease progression, driving the destruction of β-islet cells, causing hyperglycemia and ultimately death. Disease progression did not correlate with functional or numerical alterations among the HA-specific CD4+ T cells. Rather, the transferred CD8+ T cells accumulated in the pancreatic islets and a considerable fraction converted, under the control of IL-12, to an IFN-γ–producing phenotype. Our data indicate that Tc17 cells are not diabetogenic but can potentiate a Th1-mediated disease. Plasticity of the Tc17 lineage is associated with transition to overt disease in this experimental model of T1D.


  • T Cell Apoptosis and Induction of Foxp3+ Regulatory T Cells Underlie the Therapeutic Efficacy of CD4 Blockade in Experimental Autoimmune Encephalomyelitis

    by Joana Duarte, Nadège Carrié, Vanessa G. Oliveira, Catarina Almeida, Ana Agua-Doce, Lénia Rodrigues, J. Pedro Simas, Lennart T. Mars, Luis Graca

    The pathogenesis of multiple sclerosis requires the participation of effector neuroantigen-specific T cells. Thus, T cell targeting has been proposed as a promising therapeutic strategy. However, the mechanism underlying effective disease prevention following T cell targeting remains incompletely known. We found, using several TCR-transgenic strains, that CD4 blockade is effective in preventing experimental autoimmune encephalopathy and in treating mice after the disease onset. The mechanism does not rely on direct T cell depletion, but the anti-CD4 mAb prevents the proliferation of naive neuroantigen-specific T cells, as well as acquisition of effector Th1 and Th17 phenotypes. Simultaneously, the mAb favors peripheral conversion of Foxp3+ regulatory T cells. Pre-existing effector cells, or neuroantigen-specific cells that undergo cell division despite the presence of anti-CD4, are committed to apoptosis. Therefore, protection from experimental autoimmune encephalopathy relies on a combination of dominant mechanisms grounded on regulatory T cell induction and recessive mechanisms based on apoptosis of neuropathogenic cells. We anticipate that the same mechanisms may be implicated in other T cell-mediated autoimmune diseases that can be treated or prevented with Abs targeting T cell molecules, such as CD4 or CD3.


  • Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients

    by Guillaume Martin-Blondel, Lennart T. Mars, Roland S. Liblau

    The immune reconstitution inflammatory syndrome (IRIS) is an important clinical complication in HIV-infected patients initiating antiretroviral therapy. This review focuses on the latest literature pertaining to the pathogenesis of IRIS. The clinical manifestations of IRIS are heterogeneous due to the variety of opportunistic infections that are associated with this inflammatory syndrome. However, the disproportionate inflammation is a defining hallmark for which common mechanisms are suspected. Lymphopenia-induced proliferation in the context of systemic immune activation, presence of high antigenic exposure and a wider availability of interleukin-7 contribute to the exacerbated immune response underlying IRIS. Defect in pathogen clearance by phagocytes might favor high pathogen burden, which in turn is thought to activate both innate immune cells and pathogen-specific T cells upon correction of the CD4 T-cell lymphopenia, predisposing to IRIS. This common scenario might be further invigorated by functional impairments among regulatory T cells. Further insight into the cellular mechanisms driving IRIS is urgently needed. Understanding the relative contribution of distinct effector and regulatory T-cell subsets, and innate immune components to IRIS is required to inspire future therapeutic approaches.